Entrepreneur Briefs

A Rose By Any Other Color... We all know that biotechnology is important—it is a powerful tool that holds the key to the future of medicine and many other industries. But when—before now—has it ever been fun? Some scientists may have always suspected that the new science had its frivolous side, and now DNA Plant Technology (Cinnaminson, N.J.) intends to exploit it. DNAP, which recently merged with Advanced Genetic Sciences (Oakland, Calif.), announced recently that it had exp

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

We all know that biotechnology is important—it is a powerful tool that holds the key to the future of medicine and many other industries. But when—before now—has it ever been fun? Some scientists may have always suspected that the new science had its frivolous side, and now DNA Plant Technology (Cinnaminson, N.J.) intends to exploit it. DNAP, which recently merged with Advanced Genetic Sciences (Oakland, Calif.), announced recently that it had expanded the scope of its research to include work in cut flowers. With Zeadunie, a Dutch firm, and Rabobank Nederland Biotechnology Venture Fund, DNAP has created a joint venture known as Flowergene, through which it will develop flowers with novel colors, patterns and extended. Although John R. Bedbrook, executive vice president and director of scIence, isn’t free to say which varieties of flowers DNAP will focus upon, he does admit that they are the four top-selling flower species by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies